Cargando…

A Multicenter Phase III Study to Evaluate the Efficacy and Safety of Hepabulin, a New Hepatitis B Immunoglobulin, in Liver Transplantation Recipients with Hepatitis B

BACKGROUND: This study was performed to evaluate the effects and stability of the new hepatitis B immunoglobulin (HBIG), Hepabulin, in patients undergoing liver transplantation for hepatitis B. MATERIAL/METHODS: A total of 87 patients undergoing liver transplantation for hepatitis B-related liver di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Ho Joong, Kim, Dong Goo, Kim, Soon Il, Wang, Hee Jung, Joh, Jae Won, Suh, Kyung Suk, Kim, Seong Hoon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2017
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248297/ https://www.ncbi.nlm.nih.gov/pubmed/29229898 http://dx.doi.org/10.12659/AOT.905898

Ejemplares similares

Antibodies against Hepatitis A and Hepatitis B Virus in Intravenous Immunoglobulin Products
por: Lee, Soyoung, et al.
Publicado: (2016)

Cost-effectiveness and long-term outcomes of liver transplantation using hepatitis B core antibody-positive grafts with hepatitis B immunoglobulin prophylaxis in Korea
por: Kim, Kyeong Deok, et al.
Publicado: (2021)

Hepatitis B immunoglobulin prophylaxis for de novo hepatitis B infection in liver transplantation: a 30-year experience
por: Jung, Hye-Sol, et al.
Publicado: (2022)

Management of Clevudine-Resistant Chronic Hepatitis B: A Multicenter Cohort Study
por: Cho, Eun Young, et al.
Publicado: (2017)

Noncirrhotic hepatocellular carcinoma: etiology and occult hepatitis B virus infection in a hepatitis B virus-endemic area
por: Shim, Chang Woo, et al.
Publicado: (2017)

Use of direct antiviral agents in liver transplant recipients with hepatitis C virus in Korea: 2-center experience
por: Kim, Jong Man, et al.
Publicado: (2018)

Expression of Hepatocyte Hepatitis B Core Antigen and Hepatitis B Surface Antigen as a Marker in the Management of Chronic Hepatitis B Patients
por: Yim, Sun Young, et al.
Publicado: (2017)

A 6-month mixed-effect pharmacokinetic model for post-transplant intravenous anti-hepatitis B immunoglobulin prophylaxis
por: Han, Seunghoon, et al.
Publicado: (2017)

Identification of novel susceptibility loci associated with hepatitis B surface antigen seroclearance in chronic hepatitis B
por: Kim, Tae Hyung, et al.
Publicado: (2018)

Hepatitis B virus reactivation after radiotherapy for hepatocellular carcinoma and efficacy of antiviral treatment: A multicenter study
por: Jun, Baek Gyu, et al.
Publicado: (2018)

Hepatitis B Vaccine and Immunoglobulin: Key Concepts
por: Das, Saibal, et al.
Publicado: (2019)

Immunosuppression status of liver transplant recipients with hepatitis C affects biopsy-proven acute rejection
por: Kim, Jong Man, et al.
Publicado: (2016)

Determination of Hepatitis B Immunoglobulin Infusion Interval Using Pharmacokinetic Half-life Simulation for Posttransplant Hepatitis B Prophylaxis
por: Hwang, Shin, et al.
Publicado: (2019)

A multicenter experience with generic mycophenolate mofetil conversion in stable liver transplant recipients
por: Kim, Jong Man, et al.
Publicado: (2014)

Hepatitis B Core Antigen Expression in Hepatocytes Reflects Viral Response to Entecavir in Chronic Hepatitis B Patients
por: Lee, Jeong Guil, et al.
Publicado: (2013)

Efficacy of antepartum administration of hepatitis B immunoglobulin in preventing mother‐to‐child transmission of hepatitis B virus
por: Zhao, Mengyu, et al.
Publicado: (2019)

Better survival of patients with hepatitis B virus-related hepatocellular carcinoma in South Korea: Changes in 16-years cohorts
por: Choi, Sang Il, et al.
Publicado: (2022)

Misleading hepatitis B testing in the setting of intravenous immunoglobulin
por: Ilboudo, Christelle M, et al.
Publicado: (2013)

Quasispecies and Pre-Existing Drug-Resistant Mutations of Hepatitis B Virus in Patients with Chronic Hepatitis B
por: Kim, Do Young, et al.
Publicado: (2013)

Histologic Study of Chronic Active Hepatitis C; Comparison with Chronic Active Hepatitis B
por: Hahm, Ki Baik, et al.
Publicado: (1992)

Prospective Validation of FibroTest in Comparison with Liver Stiffness for Predicting Liver Fibrosis in Asian Subjects with Chronic Hepatitis B
por: Kim, Beom Kyung, et al.
Publicado: (2012)

Opsonophagocytic Antibodies to Serotype Ia, Ib, and III Group B Streptococcus among Korean Infants and in Intravenous Immunoglobulin Products
por: Kim, Han Wool, et al.
Publicado: (2017)

Is Hepatitis B Immunoglobulin Necessary in Prophylaxis of Hepatitis B Recurrence after Liver Transplantation? A Meta-Analysis
por: Wang, Peijie, et al.
Publicado: (2014)

Recurrence of Hepatitis B Infection in Liver Transplant Patients Receiving Long-Term Hepatitis B Immunoglobulin Prophylaxis
por: Beckebaum, Susanne, et al.
Publicado: (2018)

Correlation between Hepatitis B Virus Infection and Colorectal Neoplasia
por: Jung, Yoon Suk, et al.
Publicado: (2019)

Current Antiviral Therapy for Chronic Hepatitis B
por: Lim, Young-Suk, et al.
Publicado: (2004)

Significance of Hepatitis B Recurrence in Liver Transplantation Recipients
por: Chou, Hong-Shiue, et al.
Publicado: (2020)

Safety and efficacy of tenofovir in chronic hepatitis B-related decompensated cirrhosis
por: Lee, Soon Kyu, et al.
Publicado: (2017)

Association between hepatic steatosis and the development of hepatocellular carcinoma in patients with chronic hepatitis B
por: Lee, Yun Bin, et al.
Publicado: (2019)

Influence of hepatic steatosis on the outcomes of patients with chronic hepatitis B treated with entecavir and tenofovir
por: Kim, David Sooik, et al.
Publicado: (2019)

Recurrence-associated pathways in hepatitis B virus-positive hepatocellular carcinoma
por: Kim, Bu-Yeo, et al.
Publicado: (2015)

Hepatitis B surface antigen titer is a good indicator of durable viral response after entecavir off-treatment for chronic hepatitis B
por: Lee, Han Ah, et al.
Publicado: (2016)

Dermatomyositis associated with hepatitis B virus-related hepatocellular carcinoma
por: Yang, Suh Yoon, et al.
Publicado: (2014)

Primary Hepatic Small-Cell Carcinoma Developed during Antiviral Treatment for Chronic Hepatitis B
por: Kim, Suk Bae
Publicado: (2015)

Outcomes of hepatitis B immunoglobulin and hepatitis B vaccination in high-risk newborns born to HBeAg-positive mothers
por: Wu, Chen-Hsuan, et al.
Publicado: (2022)

Influence of Besifovir Dipivoxil Maleate Combined with L-Carnitine on Hepatic Steatosis in Patients with Chronic Hepatitis B
por: Jung, Yeon Woo, et al.
Publicado: (2020)

Tenofovir does not induce renal dysfunction compared to entecavir in post-liver-transplant hepatitis B virus patients
por: Kim, Sang Jin, et al.
Publicado: (2020)

Outcome of Intravenous Immunoglobulin-Transmitted HTLV-I, Hepatitis B, Hepatitis C, and HIV infections
por: Foroughipour, Mohsen, et al.
Publicado: (2013)

Efficacy of Pegylated Interferon Monotherapy versus Sequential Therapy of Entecavir and Pegylated Interferon in Hepatitis B e Antigen-Positive Hepatitis B Patients: A Randomized, Multicenter, Phase IIIb Open-Label Study (POTENT Study)
por: Jun, Dae Won, et al.
Publicado: (2018)

Risk assessment of hepatocellular carcinoma development for indeterminate hepatic nodules in patients with chronic hepatitis B
por: Shin, Haneulsaem, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_deeccoe6nvtj1npqhp6qqm2hsr